ta — receptory w chorobach układu krążenia. Pol. Arch. Med. Wewn. 1971, 46, 525.
35. Kinsella, D., Troup, W., Mc Gregor, M.: Stu-dies with a new coronary wasodilator drug: Persan-tin. Am. Heart J. 1962, 63, 146.
36. Knoebel, S. B., Mc Henry, P. L., Bonner, A. J., Philips, J. FMyocardial blood flow in coronary ar-tery disease. Effect of hight aterial pacing and ni-troglicerin. Circulation 1973, 47, 690.
37. Król, W., Kolarzowska, B., Gabryś, D Porównanie działania propranololu i LB 46 w chorobie wieńcowej serca. Przegl. Lek. 1970, 26, 726.
38. Kuch, J., Ceremużyński, L.\ Przewlekła oporna niewydolność wieńcowa (przyczyny i leczenie). Pol. Arch. Med. Wewn. 1974, 51, 457.
39. Kukove*z, W. R Effects of a new type beta — adrenergic stimulant, oxyfedrine, on cardiac performance, phosphorylase activity and efficiency. W: Cir-culatory Drugs — Red.: A. Bar telli, North — Holland Publ. Comp. Amsterdam — London 1969, 40.
40. Lee, S. J. K., Srug, Y. K., Zaragosa, A. J Effects of nitroglicerin on left ventricular volume and wali tension in patients with ischaemic heart disease. Brit. Heart J. 1970, 32, 790.
41. Lichtlen, P.\ Zur Therapie der Angina pectoris in heutigen Sicht. Zschr. fur Kreislaufforsch. 1972, 3, 193.
42. Livesley, B., Catley, P. F., Campbell, R. C., Oram, S.: Doubleblind evaluation of Verapamil, Pro-pranolol and Isosorbide against a placebo in the tre-atment of angina pectoris. Brit. Med. J. 1973, 1, 375.
43. Logue, R. B., Robinson, P. H.: Meaical Management of Angina Pectoris. Circulation 1972, 46, 1132.
44. Łukasik, S., Wrabiec, K., Stańkowska, K., Janicka, K.: Leczenie dławicy piersiowej beta — blo-kerami. Próba krytycznej oceny. Pol. Tyg. Lek. 1973, 28, 17.
45. Markiewicz, M., Bielak, J., Zninkowska, V.: Ildamen w leczeniu choroby wieńcowej. Pol. Tyg. Lek. 1972, 27, 1176.
46. Markiewicz, M., Korolko, A., Kruczkowska, E Ocena kliniczna preparatu „Intencordin”. Pol. Tyg. Lek. 1972. 27, 736.
47. Mason, D. T., Braunwald, E.: The effects of nitroglicerin and amyl nitrite on arteriolar and ve-nous tonę in the human forearm. Circulation 1965, 32, 755.
48. Mills, E. A., Downes, E. M.: Verapamil and cardiac pain (Lettcr to the editor). Lancet 1967, 2, 1149.
49. Mueller, O.: The effect of nitroglicerin and amyl — nitrite on central hemodynamics in patients with coronary heart disease. Adv. Cardiol. 1970, 4, 267.
50. Musiał, W., Tracz, W., Krzemińska-Pakuła, AL: Jednoczesne stosowanie propranololu i leków zwiększających ukrwienie serca w chorobie wieńcowej. Pol. Tyg. Lek. 1969, 24. 875.
51. Musiał, W.: Wypowiedź w Konferencji Okrągłego Stołu pt.: Zastosowanie środków blokujących beta receptory w chorobach układu krążenia. Pol. Arch. Med. Wewn. 1973, 50, 341.
52. Needleman, P., Lang, S., Johnson, E. M. Jr.‘ Organie nitrates. Relationshop between biotransfor-mation and rational angina pectoris therapy. J. Phar-macol. Exp. Ther. 1972, 181, 489.
53. Neumann, AL, Luisada, A. A.: Double — blind evaluation of orally administered Iproveratril in patients with angina pectoris. Amer. J. Med. Sci. 1966, 89, 552.
54. Parker, I. O., Case, R. B., Khaja, F., Ledwich,
I. R., Armstrong, P. W.: The influence of changes in blood volume on angina pectoris: A study of the effects of phlebotomy. Circulation 1970, 41, 593.
55. Phear, D. N.: Verapamil in Angina a Double — blind Trial. Brit. Med. J. 1968, 2, 740.
56. Prichard, B. N. C., Gillam, P. M. S.\ Assessment of propranolol in angina pectoris: Clinical dose res-ponse curve and effect on electrocardiogram at rest and on exercise. Brit. Heart J. 1971, 33, 473.
57. Redwood, D. R., Rosing, D. R., Goldstein, R. E., Beiser, G. D., Epstein, S. E.: Importance of the Design of on Exercise Protocol in the Evaluation of Patients with Angina Pectoris. Circulation 1971, 43, 618.
58. Riseman, I. E. F., Koretsky, S., Altman G. £.. Stereoisomeric nitrates in the treatment of angina pectoris. Amer. J. Cardiol. 1965, 15, 200.
59. Robin, E., Cowan, C., Puri, P., Ganguly, S., DeBoyrie, M. M., Stock, T., Bing, R. J.\ A compara-tive study of nitroglicerin and propranolol. Circulation 1967, 36, 175.
60. Russek, H. 1.: Therapeutic role of coronary va-sodilators: Glyceryl trinitrate, isosorbide dinitrate and pentaerythritol tetranitrate. Amer. J. Med. Sci. 1966, 252, 9.
61. Sampson, J. J., lliatt, K. H.: Management of the patient with severe angina pectoris. An. Internista Point of View. Circulation 1972, 44, 1185.
62. Sandler, G., Clayton, G. A.: Clinical evaluation of practolol, a new cardioselective beta — blocking agent in angina pectoris. Brit. Med. J. 1970, 2, 399.
63. Sawayama, T., Tohara, M., Katsumo, H., Nezno, S.: Polygraphic studies of the effect of nitroglicerin in patients with ischaemic heart disease. Brit. Heart
J. 1973, 35, 1234.
64. Schmid, E., Krautheim, I., Weist, F.: Clinico--pharmacological studies with prenylamine and other coronary dilating drugs. W: Circulatory Drugs. Red.: A. Bartinelli. North — Holland Publ. Comp. Amsterdam. London 1969, 83.
65. Sterkowicz, S., Kowrygo, W.: Zastosowanie eral-dyny w leczeniu choroby wieńcowej. Kardiol. Pol. 1972, 15, 221.
66. Wendkos, M. H., Meshulam, N.: Comparative
effects of placebo and sustained — release nitroglicerin in anginal subjeets. J. Clin. Pharmacol. 1973, 13, 160.
67. Williams, J. F., Glick, G., Braunwald, E.: Studies on cardiac dimensions in intact unanesthetized man. V. Effects of Nitroglicerin. Circulation 1965, 32, 767.
68. Winbury, M. M., Howe, B. B., Weiss, H. R.: Effect of nitroglicerin and dipyridamole on epicar-dial and endocardial oxygen tension — further evi-dence for redistribution of myocardial blood flow. J Pharmacol. Exp. Ther. 1971, 176, 184.
69. Winsor, T., Bleifer, K., Cole, S., Goldman, I. R Karpman, H., Stone, S., Oblath, R.: A double — blind double — cross — over trial of prenylamine in angina pectoris. Amer. Heart J. 1971, 82, 43.
70. Wolfson, S., Gorlin, J.: Cardiovascular phar-
578
PRZEGLĄD LEKARSKI 1975 32 Nr 7